iScience (Sep 2022)

SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype

  • Kazutaka Terahara,
  • Takashi Sato,
  • Yu Adachi,
  • Keisuke Tonouchi,
  • Taishi Onodera,
  • Saya Moriyama,
  • Lin Sun,
  • Tomohiro Takano,
  • Ayae Nishiyama,
  • Ai Kawana-Tachikawa,
  • Tetsuro Matano,
  • Takayuki Matsumura,
  • Masaharu Shinkai,
  • Masanori Isogawa,
  • Yoshimasa Takahashi

Journal volume & issue
Vol. 25, no. 9
p. 104959

Abstract

Read online

Summary: Determinants of memory T cell longevity following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remain unknown. In addition, phenotypes associated with memory T cell longevity, antibody titers, and disease severity are incompletely understood. Here, we longitudinally analyzed SARS-CoV-2-specific T cell and antibody responses of a unique cohort with similar numbers of mild, moderate, and severe coronavirus disease 2019 cases. The half-lives of CD4+ and CD8+ T cells were longer than those of antibody titers and showed no clear correlation with disease severity. When CD4+ T cells were divided into Th1-, Th2-, Th17-, and Tfh-like subsets, the Th17-like subset showed a longer half-life than other subsets, indicating that Th17-like cells are most closely correlated with T cell longevity. In contrast, Th2- and Tfh-like T cells were more closely correlated with antibody titers than other subsets. These results suggest that distinct CD4+ T cell subsets are associated with longevity and antibody responses.

Keywords